American society is known to be a litigious one, a stereotype that author David M. Engel sought to dispel in his book, “The Myth of the Litigious Society: Why We Don’t Sue.” A large factor in that American stereotype is likely the sort of media coverage given to certain sensational lawsuits.
Just recently, personal product maker Johnson & Johnson was in a Reuters report after it used in its defense, a recent U.S. Supreme Court ruling. That ruling says state courts are not allowed to hear claims cases involving out-of-state parties if the alleged injuries did not happen in the state. One judge already declared a mistrial in one J&J lawsuit since the plaintiffs came from out-of-state.
The ruling will likely be used by J&J to its advantage as it faces more than $300 million in verdicts from talc-related lawsuits.
There was an earlier lawsuit that Johnson & Johnson lost. In February 2016, a court found the company guilty of “negligence, conspiracy and failure” to warn women against the cancer risk talcum powder brings. The court ordered $72 million paid to the kin of the plaintiff, who died of ovarian cancer.
It should be noted that the verdict did not establish scientific proof that talcum powder does cause cancer; merely that J&J failed to warn consumers about the risk. The American Cancer Society says that evidence for cancer risk in talcum powder is mixed.
In the same vein, tobacco company Philip Morris was ordered to pay nearly $29 billion in punitive and compensatory damages in 2002. A court ruled the company failed to warn consumers about tobacco health risks. Another sensational case involved breast implant maker Dow Corning in 1998. A class action suit alleged that the company’s silicone breast implants were rupturing and causing bodily damage, and even death. Dow Corning settled the case for $2 billion.
Now, with the new US Supreme Court ruling, plaintiffs and their personal injury lawyers will have to rethink their strategies on how to hold companies liable for violations.
Pharma Mar’s first-quarter profit fell 66% to 24 million
Pharma Mar's investment in research and development (R&D) rose by 19.6% to $17.7 million (€14.7 million). Other operating expenses fell...
Bitcoin’s price facing more problems: BTC moves to exchanges as the market gets greedier
An indicator that is also not unknown is back, always urging caution. According to the Crypto Fear & Greed Index,...
Climate change has top priority in engagement with companies for AllianzGI
In the 2020 Stewardship Report, AllianzGI reports on last year's engagement activities. AllianzGI engaged with 224 companies in 29 markets...
Equity crowdfunding: record collection of 2.7 million for Homepal
The proptech company Homepal, the first digital real estate agency on the Italian market, has exceeded in just 3 days...
INTA will cultivate cannabis in Santa Fe
The goal of cultivating cannabis in the province of Santa Fe is distant, not in time but in the administrative...
Cannabis4 days ago
Morocco, the world’s largest cannabis producer legalizes it
Business3 days ago
Silver Bugs Unite on Squeeze to Send the Metal’s Price ‘to the Moon’
Featured6 days ago
Italian fintech company Credimi securitizes €200m of loans to SMEs
Crowdfunding6 days ago
A study by the Crowdfunding Observatory reveals important data for 2020